Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

A gene-based recessive diplotype exome scan discovers FGF6, a novel hepcidin-regulating iron metabolism gene.

Guo S, Jiang S, Epperla N, Ma Y, Maadooliat M, Ye Z, Olson B, Wang M, Kitchner T, Joyce J, Strenn R, Mazza JJ, Meece JK, Wu W, Jin L, Smith JA, Wang J, Schrodi SJ.

Blood. 2019 Feb 27. pii: blood-2018-10-879585. doi: 10.1182/blood-2018-10-879585. [Epub ahead of print]

PMID:
30814063
2.

Meta-GWAS and Meta-Analysis of Exome Array Studies Do Not Reveal Genetic Determinants of Serum Hepcidin.

Galesloot TE, Verweij N, Traglia M, Barbieri C, van Dijk F, Geurts-Moespot AJ, Girelli D, Kiemeney LA, Sweep FC, Swertz MA, van der Meer P, Camaschella C, Toniolo D, Vermeulen SH, van der Harst P, Swinkels DW.

PLoS One. 2016 Nov 15;11(11):e0166628. doi: 10.1371/journal.pone.0166628. eCollection 2016.

3.

Heterozygous Mutations in BMP6 Pro-peptide Lead to Inappropriate Hepcidin Synthesis and Moderate Iron Overload in Humans.

Daher R, Kannengiesser C, Houamel D, Lefebvre T, Bardou-Jacquet E, Ducrot N, de Kerguenec C, Jouanolle AM, Robreau AM, Oudin C, Le Gac G, Moulouel B, Loustaud-Ratti V, Bedossa P, Valla D, Gouya L, Beaumont C, Brissot P, Puy H, Karim Z, Tchernitchko D.

Gastroenterology. 2016 Mar;150(3):672-683.e4. doi: 10.1053/j.gastro.2015.10.049. Epub 2015 Nov 12.

4.

Update on iron metabolism and molecular perspective of common genetic and acquired disorder, hemochromatosis.

Yun S, Vincelette ND.

Crit Rev Oncol Hematol. 2015 Jul;95(1):12-25. doi: 10.1016/j.critrevonc.2015.02.006. Epub 2015 Feb 18. Review.

PMID:
25737209
5.

Hepcidin: A Promising Therapeutic Target for Iron Disorders: A Systematic Review.

Liu J, Sun B, Yin H, Liu S.

Medicine (Baltimore). 2016 Apr;95(14):e3150. doi: 10.1097/MD.0000000000003150. Review.

6.

Molecular mechanisms regulating hepcidin revealed by hepcidin disorders.

Camaschella C, Silvestri L.

ScientificWorldJournal. 2011 Jul 7;11:1357-66. doi: 10.1100/tsw.2011.130. Review.

7.

Gender-related variations in iron metabolism and liver diseases.

Harrison-Findik DD.

World J Hepatol. 2010 Aug 27;2(8):302-10. doi: 10.4254/wjh.v2.i8.302.

8.

Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders.

Kaneko Y, Miyajima H, Piperno A, Tomosugi N, Hayashi H, Morotomi N, Tsuchida K, Ikeda T, Ishikawa A, Ota Y, Wakusawa S, Yoshioka K, Kono S, Pelucchi S, Hattori A, Tatsumi Y, Okada T, Yamagishi M.

J Gastroenterol. 2010 Nov;45(11):1163-71. doi: 10.1007/s00535-010-0259-8. Epub 2010 Jun 9.

PMID:
20533066
9.

Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice.

Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S.

Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8780-5. Epub 2001 Jul 10.

10.

Hepcidin: Homeostasis and Diseases Related to Iron Metabolism.

Reichert CO, da Cunha J, Levy D, Maselli LMF, Bydlowski SP, Spada C.

Acta Haematol. 2017;137(4):220-236. doi: 10.1159/000471838. Epub 2017 May 18. Review.

PMID:
28514781
11.

Progress in iron metabolism research.

Kawabata H.

Rinsho Ketsueki. 2017;58(10):1864-1871. doi: 10.11406/rinketsu.58.1864. Japanese.

PMID:
28978826
12.

Juvenile hemochromatosis associated with heterozygosity for novel hemojuvelin mutations and with unknown cofactors.

Pelusi S, Rametta R, Della Corte C, Congia R, Dongiovanni P, Pulixi EA, Fargion S, Fracanzani AL, Nobili V, Valenti L.

Ann Hepatol. 2014 Sep-Oct;13(5):568-71.

14.

Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron.

Gehrke SG, Kulaksiz H, Herrmann T, Riedel HD, Bents K, Veltkamp C, Stremmel W.

Blood. 2003 Jul 1;102(1):371-6. Epub 2003 Mar 13.

15.

Iron metabolism: State of the art.

Daher R, Karim Z.

Transfus Clin Biol. 2017 Sep;24(3):115-119. doi: 10.1016/j.tracli.2017.06.015. Epub 2017 Jul 8. Review.

PMID:
28694024
16.

Rare causes of hereditary iron overload.

Ponka P.

Semin Hematol. 2002 Oct;39(4):249-62. Review.

PMID:
12382200
17.

Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders.

Camaschella C.

Blood. 2005 Dec 1;106(12):3710-7. Epub 2005 Jul 19. Review.

18.

New thiazolidinones reduce iron overload in mouse models of hereditary hemochromatosis and β-thalassemia.

Liu J, Liu W, Liu Y, Miao Y, Guo Y, Song H, Wang F, Zhou H, Ganz T, Yan B, Liu S.

Haematologica. 2019 Feb 21. pii: haematol.2018.209874. doi: 10.3324/haematol.2018.209874. [Epub ahead of print]

19.

Hfe and Hjv exhibit overlapping functions for iron signaling to hepcidin.

Kent P, Wilkinson N, Constante M, Fillebeen C, Gkouvatsos K, Wagner J, Buffler M, Becker C, Schümann K, Santos MM, Pantopoulos K.

J Mol Med (Berl). 2015 May;93(5):489-98. doi: 10.1007/s00109-015-1253-7. Epub 2015 Jan 23.

PMID:
25609138
20.

Iron as a Therapeutic Target in HFE-Related Hemochromatosis: Usual and Novel Aspects.

Loréal O, Cavey T, Robin F, Kenawi M, Guggenbuhl P, Brissot P.

Pharmaceuticals (Basel). 2018 Nov 26;11(4). pii: E131. doi: 10.3390/ph11040131. Review.

Supplemental Content

Support Center